Bayer AG (BAYRY)
14.04
-0.23 (1.61%)
Latest Headlines
Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road
September 10, 2026 3:54 PM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR65 at HSBC
September 10, 2026 3:28 AM - StreetInsider
FDA grants Bayer's HYRNUO accelerated approval as first-line NSCLC therapy
September 9, 2026 10:22 PM - StreetInsider
U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer
September 9, 2026 10:21 PM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR70 at Barclays
September 8, 2026 5:38 AM - StreetInsider
BofA Securities Reiterates Buy Rating on Bayer AG (BAYN:GR) (BAYRY)
September 4, 2026 6:06 AM - StreetInsider
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026
August 30, 2026 7:45 AM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR59 at Kepler Cheuvreux
August 26, 2026 4:49 AM - StreetInsider
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026
August 20, 2026 8:00 AM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR53.50 at Berenberg
August 18, 2026 5:05 AM - StreetInsider
LYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer
August 17, 2026 2:21 PM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR61 at JPMorgan
August 6, 2026 4:37 AM - StreetInsider
One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin
July 28, 2026 8:00 AM - BizWire
New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters
July 23, 2026 1:03 PM - BizWire
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials
July 17, 2026 8:30 AM - BizWire
Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming
July 14, 2026 8:10 AM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays
July 14, 2026 4:51 AM - StreetInsider
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR65 at Morgan Stanley
July 9, 2026 7:42 AM - StreetInsider
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR55 at Berenberg
July 8, 2026 4:41 AM - StreetInsider
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials
July 7, 2026 10:00 AM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR62.50 at Goldman Sachs
July 6, 2026 8:26 AM - StreetInsider
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart
July 2, 2026 8:00 AM - BizWire
Deutsche Bank Upgrades Bayer AG (BAYN:GR) (BAYRY) to Buy
July 2, 2026 3:54 AM - StreetInsider
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon
July 1, 2026 6:33 PM - BizWire
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR49 at BMO Capital
June 30, 2026 8:48 AM - StreetInsider
Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR46 at Jefferies
June 26, 2026 4:57 AM - StreetInsider
Bayer and Iambic partner on AI-driven small molecule drug discovery
June 22, 2026 8:01 AM - StreetInsider
Bayer and Iambic Collaborate to Advance Drug Discovery with AI
June 22, 2026 8:00 AM - BizWire
UBS says we are entering a catalyst rich period for this big pharma stock
June 21, 2026 10:00 AM - StreetInsider
Bayer names Kacy Perry head of Crop Science Canada
June 18, 2026 3:22 PM - StreetInsider
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada
June 18, 2026 3:22 PM - BizWire
Full Article List